Herpes Zoster Following a Nucleoside-Modified Messenger RNA COVID-19 Vaccine.
Cutis
; 109(1): E5-E7, 2022 Jan.
Article
em En
| MEDLINE
| ID: mdl-35180059
ABSTRACT
Herpes zoster (HZ) was suspected as a predictive cutaneous manifestation of COVID-19, with a debated prognostic significance. We report a series of 5 cases of HZ occurring after vaccination with a nucleoside-modified messenger RNA (mRNA) COVID-19 vaccine (Comirnaty, Pfizer-BioNTech). These new cases do not prove causality between COVID-19 vaccination and HZ. The pathophysiologic mechanism remains elusive, but local vaccine-induced immunomodulation may be involved. The occurrence of HZ does not justify avoiding the second injection of vaccine due to the benefit of vaccination.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Vacina contra Herpes Zoster
/
COVID-19
/
Herpes Zoster
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article